Eyeworld

UPDATE 13 like the perfect culmination of all the hard work that went into the projects. As I mentioned, I look forward to the YES events and look forward to attending them again this upcoming year. ASCRS Foundation: Why did you apply for the award? Would you rec- ommend other current residents and fellows apply for the award? Dr. Lee: Absolutely! There is no harm in applying for this award. Last year I was able to take full advantage of the conference with- out worrying about staying within a budget. The skills, connections, and memories I made at the confer- ence have stuck with me during my fellowship year. ASCRS Foundation: Is there any ad- vice you'd give to a future applicant or recipient of the award? Dr. Lee: Start your application early and ask your program director for a letter as soon as possible so they can write the best possible letter and ap- plication on your behalf. Take some time to explore each city you visit. ASCRS is filled with a lot of educa- tional value so make sure you take advantage of what the conference has to offer. ASCRS Foundation: What would you say to our donors who make this program possible? Dr. Lee: Thank you so much for making this experience possible! The other recipients and I appreciate all of your support in our early careers and know that our successes come with the generosity of others. To learn about the Resident Excel- lence Award, visit ascrsfoundation. org/education. Register for the 2019 ASCRS•ASOA Annual Meeting at annualmeeting.ascrs.org. EW Contact information Lee: michele.lee@ucsf.edu Morales: emorales@ascrs.org Supporting promising young surgeons by Evelyn Morales ASCRS Foundation Program Manager Profile of a 2018 Resident Excellence Award winner E ach year the ASCRS Foun- dation offers ten $1,000 Resident Excellence Awards to enable ophthalmology residents exhibiting ex- emplary performance to attend the ASCRS•ASOA Annual Meeting. The categories for consideration include research, patient care, leadership, and education. Michele Lee, MD, a 2018 Resident Excellence Award re- cipient who attended the 2018 ASCRS•ASOA Annual Meeting in Washington, D.C., shared her experience in an interview with the ASCRS Foundation staff. ASCRS Foundation: How did you learn about the Resident Excellence Award? Dr. Lee: I heard about the award from my mentors and was encour- aged to apply in order to secure funding to attend the conference. ASCRS Foundation: Tell us about your experience at the Annual Meeting. Dr. Lee: As an ophthalmology trainee, especially during the final operative year of residency, ASCRS is the most educational meeting you can attend. During my last 2 years at ASCRS, I made a point of attending as many of the YES (Young Eye Sur- geons) events as possible, which in 2018 included a day-long program with case videos and panel discus- sion, lunch with the experts, and a wet lab. At the mentored wet lab, I learned how to put in iris hooks and to perform limbal relaxing incisions, skills that came in handy during my final heavy surgical rotation of residency. ASCRS Foundation: What did you enjoy most about the meeting? Was there a particular session you were looking forward to? Dr. Lee: My favorite part of any meeting is connecting with friends and colleagues, old and new. I have also enjoyed presenting my research projects at the conference; it feels In the journal Evaluation of quality of life after implantation of a new trifocal intraocular lens Ahmet Akman, MD, Leyla Asena, MD, Caner Ozturk, MD, Sirel Gür Güngör, MD Investigators in this prospective, non-comparative case series consid- ered how patients fared in terms of quality of life after implantation of a new trifocal IOL, the PanOptix (Alcon, Fort Worth, Texas). Included in the study were 48 consecutive patients who had undergone bilateral implantation of this lens. A visual functioning index 14 (VF-14) quality of life (QOL) questionnaire was given 3 months after implantation of the second trifocal IOL. A subgroup of 14 patients with an interval of at least 3 months between the surgeries were also interviewed 3 months after monocular implantation. In this subgroup, QOL with monocular and binocular implantation was compared. The VF-14 questionnaire included a 0 to 4 point grading scale, with 0 indicating no difficulty and 4 signifying that the task was impossible to perform. Investigators determined that the most difficult tasks for those with the lens were driving at night, with a mean value of 0.89, reading small print, with a mean value of 0.94, and doing fine handwork, with of a mean of 0.64. Patient quality of life was improved with binocular implantation of the trifocal lens. Investigators concluded that with the PanOptix trifocal IOL patients have high vision-related quality of life, as well as a higher overall satisfaction rate as indicated by the mean values from the VF-14 questionnaire. Phacoemulsification of posterior polar cataracts J.L. Foster, MD, Brandon Ayres, MD, Nicole Fram, MD, Rich Hoffman, MD, Sumitra Khandelwal, MD, Gregory Ogawa, MD, Susan MacDonald, MD, Michael Snyder, MD, Abhay Vasavada, MD Posterior polar cataracts are among the most challenging and can re- quire practitioners to use different strategies than they would with other types of opacities. In this study, investigators hone in on overcoming challenges associated with posterior polar cataract removal. To increase the likelihood of success, they discuss steps practitioners can take to enable fruitful preoperative counseling and strategic surgical planning including use of a thorough preoperative exam and appropriate diag- nostics. With an eye toward keeping the posterior capsule protected as well as preserving options for IOL fixation, investigators describe specific techniques at each stage of posterior polar cataract removal. New stains for anterior capsule surgery Joanna Wilińska, MSc, Bianca Mocanu, BSc, Doaa Awad, PhD, Dimitra Gousia, Charlie Hillner, MSc, Werner Brannath, PhD, Andreas Mohr, MD, Detlef Gabel, PhD The aim of this study was to determine if new dyes or novel combi- nations of these could offer lower toxicity than existing dyes, while offering equal or better staining in anterior capsule surgery. For the study, postmortem pig eyes with induced cataracts were stained and photography used to document results. Investigators determined that reduced toxicity on corneal endothelial cells could be attained with a new cyanine dye, known as BIP ((2-[5-[3,3-dimethyl-1-(4-sulfobu- tyl)-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-1-(4- sulfobutyl)-3H-indolium sodium). By combining this green dye with trypan blue, staining here could be further enhanced. While methylene blue alone has a very toxic profile, this was reduced considerably when combined with trypan blue. Investigators concluded that the new green dye BIP allowed for safe capsule staining either alone or in combination with trypan blue. EW February 2019

• Cover